Serial Number
79329638
Owner
Suzhou Abogen Biosciences Co., Ltd.Attorney
THOMAS HOXIEFiling Date
Nov 1, 2021
ABOGENBIO Trademark
Serial Number: 79329638 • Registration: 7862325
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
THOMAS HOXIE HOXIE & ASSOCIATES LLC
75 MAIN STREET
SUITE 203
MILLBURN, NJ 07041
UNITED STATES
Trademark Details
Filing Date
November 1, 2021
Registration Date
July 15, 2025
Published for Opposition
November 22, 2022
Goods & Services
Pharmaceutical preparations for the treatment or prevention of cancer, and infectious diseases; chemico-pharmaceutical preparations for the treatment or prevention of cancer and infectious diseases; drugs being pharmaceutical preparations for medical purposes for the treatment or prevention of cancer and infectious diseases; biological preparations for the treatment or prevention of cancer and infectious diseases for medical purposes; medicines for the treatment or prevention of cancer and infectious diseases for human purposes; chemical preparations for medical purposes, namely, for the treatment or prevention of cancer and infectious diseases; crude drug being homeopathic pharmaceuticals for the treatment of infectious viral diseases;, lipid particle for nucleotide drug delivery purpose for the treatment or prevention of cancer and infectious diseases; and biochemical medicines for the treatment or prevention of cancer and infectious diseases; dietetic substances being foods and beverages adapted for medical use for the treatment or prevention of cancer and infectious diseases
Technological research in the field of medical research, specifically for the treatment or prevention of cancer and infectious diseases; quality control, specifically for products for the treatment or prevention of cancer and infectious disease; product quality testing, specifically for products for the treatment or prevention of cancer and infectious diseases; cancer research for medical purposes; pharmaceutical drug development services, specifically for pharmaceutical drugs for the treatment or prevention of cancer and infectious diseases; pharmaceutical product evaluation, namely, drug evaluation, specifically for the treatment or prevention of cancer and infectious diseases; pharmaceutical research services, specifically for products for the treatment or prevention of cancer and infectious diseases; medical research, specifically for the treatment or prevention of cancer and infectious diseases; development of pharmaceutical preparations and pharmaceuticals, specifically for products for the treatment or prevention of cancer and infectious diseases
